-
Academician Gao Fu: If the world does not share the vaccine virus, it will share the world
Time of Update: 2021-11-12
Academician Gao Fu: If the world does not share the vaccine virus, it will share the world Academician Gao Fu: If the world does not share the vaccine virus, it will share the world
-
The centralized procurement of Chinese patent medicines is continuously advancing, and it is urgent for the enterprises to control costs and ensure the quality of Chinese patent medicines.
Time of Update: 2021-11-12
With the continuous advancement of centralized procurement of proprietary Chinese medicines, the industry generally believes that relevant pharmaceutical companies will face the test of price cuts .
. So, in the face of the continuous advancement of centralized procurement, how should Chinese patent medicine companies control costs and ensure quality?
-
The pharmaceutical industry has set off a financing wave, and pharmaceutical companies will accelerate the research and development of new drugs
Time of Update: 2021-11-12
. It is reported that this round of financing will be used to continue to promote the development of domestic and foreign clinical research trials of multiple drug candidates including AGA111, continue to expand the scale of the preclinical product pipeline, and further improve the creation of a management team with international experience and vision , To accelerate the industrialization of innovative drugs in the treatment of severe bone, joint and muscle diseases .
-
Huang Ailong's team from Chongqing Medical University discovers 3 new crown super-strong antibodies
Time of Update: 2021-11-12
Recently, led by Professor Huang Ailong, the new crown virus emergency response team led by Professor Jin Aishun, and the key laboratory of medical molecular virology/BSL-3 laboratory of Fudan University, the Yang Haitao research group of Shanghai University of Science and Technology, and the Zhang Bo research group of Wuhan Institute of Virology Multidisciplinary cooperation, published the latest research results titled "Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants" online in "Nature communications" .
-
The biological products sector maintains rapid growth, and the prosperity of these fields is high
Time of Update: 2021-11-12
Among them, Hotview Biopharmaceuticals issued a third-quarter results announcement on the evening of October 29, stating that the company achieved operating income of approximately 196 million yuan in the third quarter, a year-on-year increase of 252.
-
89 new confirmed cases on November 7th, 65 of which were in the mainland
Time of Update: 2021-11-12
As of 24:00 on November 7, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are 1202 confirmed cases (including 28 severe cases), a total of 91985 cured and discharged cases, and a total of 4636 deaths.
-
High success rate, fast return, new hot spot for research and development of improved new drugs
Time of Update: 2021-11-12
Therefore, as more and more pharmaceutical companies enter this field in the future, domestic improved new drugs The development process will also continue to accelerate .
-
Zhang Furen's team: "Talking about hemp" does not "discoloration"
Time of Update: 2021-11-12
In recent years, thanks to the unremitting efforts and day-night research of Chinese researchers such as Zhang Furen’s team, China has made huge technological breakthroughs in the field of leprosy prevention.
In 2013, Zhang Furen's team once again ushered in new research progress and discovered the risk allele HLA-B*13:01 for dapsone syndrome .
-
Fan Jia, Academician of the Chinese Academy of Sciences: Now there is no need to "talk about cancerous discoloration" for liver cancer
Time of Update: 2021-11-12
It is understood that after 9 years of research, Fan Jia’s team has screened seven types of microribonucleic acid (miRNA) molecular markers for early diagnosis of liver cancer in the plasma of liver cancer patients .
-
Su Shicheng: Expanding the audience for breast cancer immunotherapy
Time of Update: 2021-11-12
” Su Shicheng said, which suggests that even if PD-L1 is not expressed before treatment, combined anti-Her2 targeted therapy and anti-PD-1 /PD-L1 immunotherapy can still benefit Her2+ breast cancer patients, especially those with high macrophage infiltration .
-
Qilu Pharmaceutical once again qualified and firstly submitted the application for olaparib generic drug listing
Time of Update: 2021-11-11
In China, the original research olaparib was approved by the NMPA in December 2018 for the maintenance treatment of platinum-sensitive recurrent epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer in adult patients after platinum-containing chemotherapy has achieved complete remission or partial remission , The trade name is Lipzo .
-
On the 27th, 39 new cases were diagnosed with new crowns, including 23 in the local area
Time of Update: 2021-11-11
As of 24:00 on October 27, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 659 confirmed cases (including 33 severe cases), a total of 91,643 cured and discharged cases, and a total of 4,636 deaths.
-
Determination of early markers of diseases such as Alzheimer's disease
Time of Update: 2021-11-11
(Intern reporter Zhang Jiaxin) According to a paper recently published in the journal Science Translational Medicine, researchers at the Medical University of South Carolina and Harvard Medical University Beth Israel Deaconess Medical Center found that cis P- Tau is a toxic, non-degradable brain protein and an early marker of vascular dementia (VAD) and Alzheimer's disease (AD) .
-
A total of 247,472,724 confirmed cases of new crowns worldwide
Time of Update: 2021-11-11
Reached 5012337 cases .
-
WHO: A total of 247,968,227 confirmed cases of new crowns worldwide
Time of Update: 2021-11-11
WHO: The global cumulative number of confirmed cases of new crown reached 247,968,227 WHO: The global cumulative number of confirmed cases of COVID-19 reaches 247,968,227 WHO: The global cumulative number of confirmed cases of COVID-19 reaches 247,968,227 Xinhua News Agency, Geneva, November 4 (Reporter Liu Qu) The latest data released by the World Health Organization on the 4th showed that the total number of confirmed cases of new crown in the world reached 247,968,227 .
-
List of experts for defense review of 2 key special projects announced
Time of Update: 2021-11-11
China Biotechnology Development Center 2021-11-08 Attachment: "Research on the Modernization of Traditional Chinese Medicine" and other two key special projects, the list of experts for the defense and review of the 2021 application project.
-
Notice of the Comprehensive Department of the State Food and Drug Administration on the activation of the API production and supply information collection module
Time of Update: 2021-11-11
Relevant API manufacturers shall fill in their API production and supply information through the API production and supply information collection module, and submit it online to the provincial drug supervision and administration department where the API manufacturers are located .
-
Novo Nordisk's basal insulin GLP-1RA injection Novo benefit® was approved in China
Time of Update: 2021-11-11
Yi Novo ® is the world's first basal insulin glucagon-like peptide-1 receptor agonist (GLP-1RA) injection , the insulin and liraglutide Germany Valley composition 2 , the integration of the breakthrough insulin Germany Valley Liraglutide has two-component advantages, complementary mechanisms, multi-targeted action on multiple pathophysiological mechanisms of type 2 diabetes 3,4,5 , once a day injection, powerful control of blood sugar throughout the day, glycosylated hemoglobin (HbA 1c ) reaches the standard The rate is as high as 89.
-
Scientists uncover the frontier secrets of cancer immunotherapy
Time of Update: 2021-11-11
Scientists uncover the frontier secrets of cancer immunotherapy Scientists uncover the frontier mystery of cancer immunotherapyScientists uncover the frontier mystery of cancer immu
-
The current round of the epidemic in Heihe City, Heilongjiang Province identified as the Delta mutant strain
Time of Update: 2021-11-11
The current round of the epidemic in Heihe City, Heilongjiang Province identified as the Delta mutant strain The current round of the epidemic in Heihe City, Heilongjiang Province w
